iRhythm Technologies Inc. (IRTC)
NASDAQ: IRTC
· Real-Time Price · USD
142.78
0.34 (0.24%)
At close: May 23, 2025, 3:59 PM
141.51
-0.89%
After-hours: May 23, 2025, 04:14 PM EDT
iRhythm Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Centers For Medicare And Medicaid Revenue | 142.39M | 122.41M | 103.03M | 44.53M | 72.54M | 58.92M | 40.55M |
| Centers For Medicare And Medicaid Revenue Growth | +16.32% | +18.81% | +131.38% | -38.61% | +23.11% | +45.29% | n/a |
| Commercial Payors Revenue | 311.61M | 267.19M | 223.98M | 193.87M | 135.94M | 43.02M | 69.36M |
| Commercial Payors Revenue Growth | +16.62% | +19.29% | +15.53% | +42.62% | +216.00% | -37.98% | n/a |
| Healthcare Institutions Revenue | 95.11M | 71M | 59.77M | 57.5M | 41.4M | 10.77M | 37.38M |
| Healthcare Institutions Revenue Growth | +33.96% | +18.79% | +3.96% | +38.89% | +284.36% | -71.19% | n/a |
| Non-contracted Third-party Payors Revenue | 42.73M | 32.07M | 24.13M | 26.93M | 15.29M | n/a | n/a |
| Non-contracted Third-party Payors Revenue Growth | +33.24% | +32.89% | -10.38% | +76.06% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 119.96M | 99.77M | 103.38M | 106.76M | 108.66M | 100.11M | 93.77M | 91.42M | 100.34M | 86.73M | 80.56M | 81.75M | 73.16M | 71.61M | 70.75M | 62.67M | 69.81M | 56.29M | 49.7M | 43.01M | 48.23M | 53.65M | 48.01M | 43.19M | 36.7M | 37.17M | 32.74M | 33.09M | 28.58M | 26.95M | 20.31M | 20.25M | 17.22M | 14.96M | 12.53M | 12.61M | 11.52M | 11.79M | 9.45M | 7.75M | 7.75M |
| Selling, General, and Administrative Revenue Growth | +20.24% | -3.49% | -3.17% | -1.75% | +8.54% | +6.77% | +2.57% | -8.89% | +15.70% | +7.66% | -1.46% | +11.75% | +2.16% | +1.23% | +12.89% | -10.23% | +24.03% | +13.25% | +15.55% | -10.81% | -10.10% | +11.75% | +11.16% | +17.67% | -1.26% | +13.54% | -1.07% | +15.81% | +6.04% | +32.71% | +0.26% | +17.60% | +15.11% | +19.43% | -0.63% | +9.43% | -2.26% | +24.80% | +21.95% | 0.00% | n/a |
| Research and Development Revenue | 21.52M | 19.38M | 15.69M | 19.69M | 16.99M | 15.42M | 16.31M | 13.68M | 14.84M | 12.68M | 11.45M | 11.95M | 10.54M | 11.87M | 8.69M | 9.61M | 8.51M | 11.6M | 8.77M | 12.54M | 8.41M | 9.27M | 12.72M | 8.64M | 6.76M | 7M | 5.16M | 4.56M | 4.02M | 4.15M | 3.79M | 2.78M | 2.62M | 2.3M | 1.64M | 1.67M | 1.54M | 1.8M | 1.65M | 1.45M | 1.45M |
| Research and Development Revenue Growth | +11.02% | +23.51% | -20.29% | +15.86% | +10.24% | -5.48% | +19.24% | -7.85% | +17.10% | +10.72% | -4.16% | +13.31% | -11.19% | +36.67% | -9.59% | +12.88% | -26.66% | +32.34% | -30.09% | +49.04% | -9.20% | -27.16% | +47.27% | +27.87% | -3.53% | +35.61% | +13.15% | +13.56% | -3.11% | +9.45% | +36.53% | +5.91% | +13.81% | +40.86% | -1.92% | +7.90% | -14.17% | +9.02% | +13.94% | 0.00% | n/a |